Pfizer Appoints Cecile Guegan as Chief Financial Officer
Pfizer's board unanimously appointed Cecile Guegan as CFO and Executive Vice President, effective November 1, 2026. Guegan had served as interim CFO since August 16, 2026 and brings over 25 years of pharmaceutical finance experience, having previously run financial operations for Pfizer's biopharmaceutical business.
Key figures
- Interim since
- August 16, 2026
- Effective date
- November 1, 2026
- Years experience
- 25+
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.